You are here: Industry Insights > Nasdaq

News List

Sinovac Biotech Announces Receipt of Delisting Determination Letter from Nasdaq prnasia
November 06, 2017
Sinovac Biotech Ltd. (Nasdaq: SVA) ("Sinovac"), a leading provider of biopharmaceutical products in China, announced today that on November 1, 2017
RNA biotech Arcturus backs onto Nasdaq in Alcobra deal fiercebiotech
September 29, 2017
The deal will give Arcturus a route to public investors at a time when interest in RNA therapies is flying high on the back of Alnylam’s phase 3 success.
Second Nasdaq compliance notice adds to Auris’ trouble fiercebiotech
August 28, 2017
Before, Nasdaq gave compliance notice to Auris about its failure to meet the minimum bid price.
Envigo merges with Avista, to be listed on Nasdaq fiercebiotech
August 25, 2017
Nonclinical service CRO Envigo is merging with Avista Healthcare Public Acquisition Corp., a deal that will value the combined company at $924 million.
Amid dwindling cash and a Nasdaq warning, MabVax seeks ‘strategic options’ fiercebiotech
August 24, 2017
This comes as it overspent on a clinical trial
Sinovac Biotech Announces Receipt of NASDAQ Letter and Delayed Filing of Annual Report on Form 20-F en-cphi.cn
May 17, 2017
Sinovac Biotech Ltd. announced today that it is delaying its Annual Report on Form 20-F for the year ended December 31, 2016 (the "2016 Annual Report") and that it received a written notice from the Listing Qualifications Department of The Nasdaq Stock Ma

Previous page 1 2 Next page